- Home
- PRAX vs COLB Comparison
PRAX vs COLB Comparison
Compare PRAX & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRAX | COLB |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 8.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRAX | COLB |
|---|---|---|
| Price | $332.84 | $31.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 14 |
| Target Price | ★ $519.60 | $31.18 |
| AVG Volume (30 Days) | 540.8K | ★ 3.0M |
| Earning Date | 02-19-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 4.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.30 |
| Revenue | $7,463,000.00 | ★ $2,151,000,000.00 |
| Revenue This Year | N/A | $32.03 |
| Revenue Next Year | $29,535.93 | $2.85 |
| P/E Ratio | ★ N/A | $13.75 |
| Revenue Growth | ★ 364.98 | 17.96 |
| 52 Week Low | $26.70 | $19.61 |
| 52 Week High | $328.60 | $32.70 |
Technical Indicators
Market Signals| Indicator | PRAX | COLB |
|---|---|---|
| Relative Strength Index (RSI) | 65.37 | 62.37 |
| Support Level | $302.00 | $30.14 |
| Resistance Level | $328.60 | $32.62 |
| Average True Range (ATR) | 16.93 | 0.88 |
| MACD | -0.13 | 0.17 |
| Stochastic Oscillator | 95.16 | 68.05 |
Price Performance
Historical ComparisonAbout PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.